REG - IP Group PLC - Further re Scrip Dividend

IPAnnouncement

29/06/2022 09:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220629:nRSc6180Qa&default-theme=true

RNS Number : 6180Q  IP Group PLC  29 June 2022

 FOR RELEASE ON  29 June 2022

 

IP Group plc - Further re Scrip Dividend

 

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops
world-changing science and technology businesses across life sciences,
technology and cleantech, announces that further to the announcement made on
06 June 2022 in relation to the Scrip Dividend, the Group has received valid
elections from certain shareholders. IP Group intends to sell Ordinary Shares
which are currently held in treasury to satisfy such elections and will
transfer these shares pursuant to the Scrip Dividend Terms and Conditions
("the Scrip Dividend Shares").

 

330,851 Scrip Dividend Shares will be transferred to relevant shareholders on
30 June 2022. Following such transfer, and in accordance with the Disclosure
Guidance and Transparency Rules of the Financial Conduct Authority, the Group
will have 1,063,033,287 Ordinary Shares in issue and 28,607,622 shares in
Treasury.

 

The total number of Ordinary Shares with voting rights following the
satisfaction of the transfer will be 1,034,425,665 Ordinary Shares. This
figure may be used by shareholders in the Group as the denominator for the
calculation by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of the Group
under the Disclosure Guidance and Transparency Rules of the Financial Conduct
Authority.

 

 

For more information, please contact:

 

 IP Group plc                                              www.ipgroupplc.com (http://www.ipgroupplc.com)
 David Baynes, Chief Financial and Operating Officer       +44 (0) 20 7444 0050

Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0062/+44 (0) 7967 312125

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life
sciences, technology and cleantech (through Kiko Ventures). The Group has a
strong track record of success, having been the founder investor in a number
of high-profile companies including Oxford Nanopore Technologies plc, and has
one of the most exciting portfolios of high-growth businesses in Europe. The
Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs
world-changing technologies emerging from the UK's leading universities and
research institutions. IP Group is listed on the Main Market of the London
Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURMZGZVRLMGZZG